Torrent Pharmaceuticals has raised funds through issuance of Commercial Paper (CPs) for an amount of approximately Rs 200 crore on May 03, 2019. The Tenure of the instrument is 136 days, having a maturity date of September 16, 2019. Credit rating agency, ICRA has granted rating of ‘A1 +’ for issuance of Commercial papers by the company.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
